La prognosi dell'epilessia dalla data della diagnosi

Translated title of the contribution: The prognosis of epilepsy from time of diagnosis

Research output: Contribution to journalArticle

Abstract

The prognosis of epilepsy from the time of its diagnosis is extensively reviewed. As most patients (>70%) who experience a second seizure have further seizures, the demonstration of at least two unprovoked seizures is a sufficient neuroepidemiological criterion for the definition of epilepsy. Once the antiepileptic treatment is instituted, the 1-year remission rates in most studies have varied between 65 and 80%. Similarly, long-term remission rates (15 to 20 years from the onset) of treated epilepsy give values around 70%. The prognosis depends on many factors: aetiology, neurological status, number and type of seizures at onset and the epileptic syndrome, the latter being the most important factor. Recent studies trying to address the early prediction of intractable epilepsy demonstrate that patients who have many seizures before therapy or who have an inadequate response to the first monotherapy are likely to have refractory epilepsy. The prognosis of untreated epilepsy is poorly understood, but data obtained from studies in developing countries seem to indicate that a high proportion of patients (50%) may enter spontaneous remission.

Original languageItalian
Pages (from-to)17-20
Number of pages4
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number121-122
Publication statusPublished - Jul 2003

Fingerprint

Epilepsy
Seizures
Spontaneous Remission
Anticonvulsants
Developing Countries
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

La prognosi dell'epilessia dalla data della diagnosi. / Michelucci, R.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 121-122, 07.2003, p. 17-20.

Research output: Contribution to journalArticle

@article{357cdcffabec4edf97c553487d961aa1,
title = "La prognosi dell'epilessia dalla data della diagnosi",
abstract = "The prognosis of epilepsy from the time of its diagnosis is extensively reviewed. As most patients (>70{\%}) who experience a second seizure have further seizures, the demonstration of at least two unprovoked seizures is a sufficient neuroepidemiological criterion for the definition of epilepsy. Once the antiepileptic treatment is instituted, the 1-year remission rates in most studies have varied between 65 and 80{\%}. Similarly, long-term remission rates (15 to 20 years from the onset) of treated epilepsy give values around 70{\%}. The prognosis depends on many factors: aetiology, neurological status, number and type of seizures at onset and the epileptic syndrome, the latter being the most important factor. Recent studies trying to address the early prediction of intractable epilepsy demonstrate that patients who have many seizures before therapy or who have an inadequate response to the first monotherapy are likely to have refractory epilepsy. The prognosis of untreated epilepsy is poorly understood, but data obtained from studies in developing countries seem to indicate that a high proportion of patients (50{\%}) may enter spontaneous remission.",
keywords = "Antiepileptic Drugs, Epilepsy, Predictors of Refractory Epilepsy, Prognosis, Syndromic Classification",
author = "R. Michelucci",
year = "2003",
month = "7",
language = "Italian",
pages = "17--20",
journal = "Bollettino - Lega Italiana contro l'Epilessia",
issn = "0394-560X",
publisher = "Lega Italiana contro l'Epilessia",
number = "121-122",

}

TY - JOUR

T1 - La prognosi dell'epilessia dalla data della diagnosi

AU - Michelucci, R.

PY - 2003/7

Y1 - 2003/7

N2 - The prognosis of epilepsy from the time of its diagnosis is extensively reviewed. As most patients (>70%) who experience a second seizure have further seizures, the demonstration of at least two unprovoked seizures is a sufficient neuroepidemiological criterion for the definition of epilepsy. Once the antiepileptic treatment is instituted, the 1-year remission rates in most studies have varied between 65 and 80%. Similarly, long-term remission rates (15 to 20 years from the onset) of treated epilepsy give values around 70%. The prognosis depends on many factors: aetiology, neurological status, number and type of seizures at onset and the epileptic syndrome, the latter being the most important factor. Recent studies trying to address the early prediction of intractable epilepsy demonstrate that patients who have many seizures before therapy or who have an inadequate response to the first monotherapy are likely to have refractory epilepsy. The prognosis of untreated epilepsy is poorly understood, but data obtained from studies in developing countries seem to indicate that a high proportion of patients (50%) may enter spontaneous remission.

AB - The prognosis of epilepsy from the time of its diagnosis is extensively reviewed. As most patients (>70%) who experience a second seizure have further seizures, the demonstration of at least two unprovoked seizures is a sufficient neuroepidemiological criterion for the definition of epilepsy. Once the antiepileptic treatment is instituted, the 1-year remission rates in most studies have varied between 65 and 80%. Similarly, long-term remission rates (15 to 20 years from the onset) of treated epilepsy give values around 70%. The prognosis depends on many factors: aetiology, neurological status, number and type of seizures at onset and the epileptic syndrome, the latter being the most important factor. Recent studies trying to address the early prediction of intractable epilepsy demonstrate that patients who have many seizures before therapy or who have an inadequate response to the first monotherapy are likely to have refractory epilepsy. The prognosis of untreated epilepsy is poorly understood, but data obtained from studies in developing countries seem to indicate that a high proportion of patients (50%) may enter spontaneous remission.

KW - Antiepileptic Drugs

KW - Epilepsy

KW - Predictors of Refractory Epilepsy

KW - Prognosis

KW - Syndromic Classification

UR - http://www.scopus.com/inward/record.url?scp=1242317699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242317699&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:1242317699

SP - 17

EP - 20

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 121-122

ER -